Effects of Carvedilol as Third-Line Add-On Therapy on Blood Pressure and Glucose Metabolism in Type 2 Diabetic Patients with Chronic Renal Disease Stage 3 and Above
2012 ◽
Vol 36
(1)
◽
pp. 131-138
◽
1991 ◽
Vol 8
(6)
◽
pp. 567-572
◽
2007 ◽
Vol 292
(1)
◽
pp. E347-E352
◽
2019 ◽
Vol 33
(7)
◽
pp. 473-476
Keyword(s):